These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6448356)

  • 1. Involvement of 5-hydroxytryptamine and dopamine neurones in the behavioural effects of alpha-methylytryptamine.
    Marsden CA
    Neuropharmacology; 1980 Aug; 19(8):691-8. PubMed ID: 6448356
    [No Abstract]   [Full Text] [Related]  

  • 2. The concentration of 5-methoxytryptamine in rat brain and its effects on behaviour following its peripheral injection.
    Green AR; Hughes JP; Tordoff AF
    Neuropharmacology; 1975 Aug; 14(8):601-6. PubMed ID: 126386
    [No Abstract]   [Full Text] [Related]  

  • 3. Some behavioural interactions between 5-hydroxytryptamine and dopamine.
    Curzon G
    Adv Exp Med Biol; 1981; 133():563-84. PubMed ID: 6459008
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles.
    Marsden CA; Curzon G
    Neuropharmacology; 1977; 16(7-8):489-94. PubMed ID: 144245
    [No Abstract]   [Full Text] [Related]  

  • 5. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade.
    Leysen JE; Van Gompel P; de Chaffoy de Courcelles D; Niemegeers CJ
    J Recept Res; 1987; 7(1-4):223-39. PubMed ID: 3625598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reserpine, para-chlorophenylalanine, 5,6-dihydroxytryptamine and fludiazepam on the head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice.
    Nakamura M; Fukushima H
    J Pharm Pharmacol; 1978 Apr; 30(4):254-6. PubMed ID: 24719
    [No Abstract]   [Full Text] [Related]  

  • 7. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of the intraventricular administration of 5-HT and dopamine in the common marmoset (Callithrix jacchus).
    Oliveira Mda P; Campos Mde F
    Pharmacol Biochem Behav; 1993 Sep; 46(1):21-5. PubMed ID: 8255914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of some tryptamine derivatives on brain monoamines and their precursor amino acids.
    Leonard BE; Shallice SA
    Neuropharmacology; 1972 May; 11(3):373-84. PubMed ID: 4262001
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and biochemical actions of p-chlorophenylethylamine (p-CPEA) in mice.
    Hwang EC; Van Woert MH
    Life Sci; 1979 Feb; 24(7):595-601. PubMed ID: 155767
    [No Abstract]   [Full Text] [Related]  

  • 15. DSP-4 lesioning prevents the enhancement of dopamine and 5-hydroxytryptamine mediated behavioural changes by repeated electroconvulsive shock.
    Heal DJ; Davies CL; Goodwin GM
    Eur J Pharmacol; 1985 Sep; 115(1):117-21. PubMed ID: 4043230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.
    Marsden CA; Curzon G
    Psychopharmacology (Berl); 1978 Apr; 57(1):71-6. PubMed ID: 149328
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of 5-hydroxytryptamine and dopamine in the behavioural effects of alpha-methyltryptamine [proceedings].
    Marsden CA
    Br J Pharmacol; 1978 Nov; 64(3):431P. PubMed ID: 719281
    [No Abstract]   [Full Text] [Related]  

  • 19. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 20. "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.
    Bedard P; Pycock CJ
    Neuropharmacology; 1977 Oct; 16(10):663-70. PubMed ID: 304190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.